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ABSTRACT 
Study Aim: To identify the criteria used to diagnose childhood tuberculosis (TB) at two 
paediatric outpatient departments in Johannesburg between 01 November 1997 and 30 
June 1998 and to compare the criteria used to those used by the World Health Organization 
in the diagnosis of childhood TB. 
Study Design: An observational descriptive, retrospective, hospital outpatient-based 
study. 
Setting: Paediatric outpatient departments of Coronation Hospital (CH) and Johannesburg 
General Hospital (JGH). 
Patients and Methods: Patients ranging from the ages of 3 months to 14 years who 
attended the two paediatric outpatient departments and were diagnosed and notified as 
having TB,  comprised the study population. Criteria used to establish the diagnosis of TB 
for each patient were extracted from patient records. Clinical history and baseline clinical 
characteristics were analysed using standard statistical methods, and criteria used to make 
a diagnosis of tuberculosis were compared to those recommended by the World Health 
Organization.  
Results: One hundred and one patients were diagnosed with TB at the two outpatient 
departments during the eight month study period. The combination of symptoms 
suggestive of active TB, which included persistent cough >1 month associated with fever, 
weight loss and loss of appetite, was more common in the JGH cohort (32 of 51 patients; 
v 
 
63%) compared to the CH cohort (10 of 50 patients; 20%); Odds Ratio (OR) 6.74 (95% 
Confidence Interval [CI], 2.54-18.41), P<0.001. 
One third (32%) of the total group of children had a positive TB exposure history. 
Tuberculin skin test (TST) reactions were positive in 86% of the total cohort, with a similar 
result being seen at both hospitals. 
Submission of specimens for microbiological assessment was not a common practice in 
either outpatient department, with 95% (96 of 101 participants) not having any specimens 
collected. 
Overall, 93% (94 of 101 participants) were classified as having ‘Probable’ TB. 
Conclusion: Criteria being used to diagnose childhood TB in the two paediatric outpatient 
departments are comparable to the WHO criteria recommended for the diagnosis of 
childhood TB. The majority of children diagnosed were classified as ‘Probable’ TB. TST was 
the main diagnostic tool used in the two outpatient departments at the time of study 
conduct.  
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                                                            Chapter 1: Introduction 
Chapter Summary 
This study was conducted in the context of the ambulatory paediatric settings at two 
academic hospitals in Johannesburg between 01 November 1997 and 30 June 1998. The 
clinical approach to diagnosing tuberculosis (TB) in children in the ambulatory setting has not 
changed significantly over the intervening time period. This chapter discusses the burden and 
epidemiology of TB, the impact of human immunodeficiency virus (HIV) infection on TB 
disease, the diagnostic approach to childhood TB and the World Health Organization (WHO) 
classification of childhood TB. 
 
1.1 INTRODUCTION 
1.1.1 The Burden of TB Internationally and Locally 
TB was declared to be  a  global  emergency  by  the  World  Health  Assembly  in  1993 (1).  
Before then, it had been a relatively neglected disease in both industrialized and 
developing countries (2). It is estimated that  a third  of  the  global  population  is  infected  
with  Mycobacterium tuberculosis (MTB),  which  infects  approximately  7-8 million  
individuals  every  year (3).  It  kills  an  estimated  3 million  people  each  year (1), being  
the  largest  cause  of  death  from  a  single  infectious  agent  in  the  world (3). In  South 
Africa,  the  burden of TB reflects  that  of   the  global  community – it  causes  more  deaths  
than  any other  infectious  disease (4)  and  is  the  most  common  notifiable  condition (5).  
Factors  contributing  to  the TB  epidemic  in  South Africa  include  the HIV epidemic,   
2 
 
accelerated  urbanization,  poverty,  improperly  managed  treatment  programmes,  and  
poor  compliance to anti-tuberculous therapy (6).  
TB is attracting  renewed  interest  locally and globally, with  significant  efforts  being 
undertaken to  revive  control  activities  because  of  the  increasing  incidence  of  HIV-
related  TB disease (7),  the threat of drug-resistant TB (8), the  availability  and  proven  
effectiveness  of  short-course  chemotherapy (9),  and  the  realization  that  TB  control  is  
one  of  the  most  cost-effective  health  interventions  in  developing  countries (2). 
Although recent advances have been made in terms of the diagnosis of TB in the 21st 
Century, with heavier reliance on molecular-based techniques such as the GeneXpert 
diagnostic assay (10) most outpatient TB diagnosis in children still relies on the classical 
approach of history, clinical examination, and the use of routine diagnostic tests, e.g. 
Mantoux, and chest x-ray. These, routine approaches have changed little over the past 
decades. 
 
1.1.2 HIV and TB 
According to the World Health Organization (WHO), South Africa now ranks first in terms 
of TB burden, with a disease incidence of 1,003 per 100,000 population (11). HIV has been 
identified to be a major contributor towards fuelling the TB epidemic in the South African 
context, with more than 70% of TB patients also living with HIV (11). The dramatic spread 
of the HIV epidemic throughout sub-Saharan Africa in the past decades has been 
accompanied by an up to fourfold increase in the number of TB cases registered by 
National TB programmes in countries in the sub-Saharan African region (12). 
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 The rising HIV epidemic has resulted in a marked increase in the incidence of adult TB (13) 
which may be either sputum smear-positive or -negative pulmonary TB (PTB). These 
adults are often parents of young children, and hence expose their children to increased 
risk of infection with MTB.  
1.1.2.1 HIV and Child TB in South Africa  
The annual risk of TB infection (ARI) amongst children living in high-burdened 
communities in South Africa is 4% (14), and this is largely driven by the HIV epidemic. As 
mentioned above, the HIV/TB epidemic has resulted in a high incidence of infectious TB 
occurring among young adults (20–40 years) (15); these are often parents of young 
children exposing their children to an increased risk of TB. 
In South Africa, there is a high prevalence (around 50%) of HIV co-infection in children 
with culture-confirmed TB (16), thus it is recommended that an HIV test be performed on 
all children suspected of having TB (15,17).   
HIV-infected children with their suppressed immune function, once infected with MTB 
have a markedly increased risk of developing TB disease. In HIV-infected children younger 
than 3 years, the risk of TB disease is four times greater in those with a low CD4 count 
(<15%), as compared to those with a higher CD4 count (≥15%) (18). Furthermore, the 
prevalence (2.7%) (19) of  HIV amongst infants and young children compounds the burden 
of TB in this age group. The risk of developing culture-confirmed TB in HIV-infected infants 
in a TB endemic setting is over 20 times higher than in HIV-uninfected infants (15, 20). 
Response to TB treatment and clinical outcome has been shown to be poorer for HIV-
infected children when compared to HIV-uninfected children (21). A substantial proportion 
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of deaths in children with HIV/TB co-infection occur in the first two months following 
commencement of TB treatment (15, 22). Compounding factors for poor treatment 
response and increased mortality include severe malnutrition, HIV related co-infections, 
chronic lung disease, severe immune-suppression and immune reconstitution 
inflammatory syndrome (IRIS) (15).     
      
 
1.1.3 Programmatic Management of TB  
TB control is, in theory, simple and highly cost-effective (23).  Passive  case-finding  and  
the  provision  of  short-course  (six-month) chemotherapy  will  cure  the  majority  of  
cases  and,  if  coverage  is  high  enough,  will  lead  to  a  sustained  reduction  in  the 
number of TB cases in high-burdened communities (16).  This is the basic strategy 
advocated by WHO and the International Union Against TB and Lung Disease (IUATLD) 
(24).    
The  main  focus  of   TB  control  has  been  on  the  detection  of  MTB in sputum smear-
positive  adults  who  spread  the  disease (i.e. infectious cases),  but if  early  detection  of  
children  with  TB  can  be  achieved,  this  will  prevent  progression  of  the  disease  in  
these  children,  and  also  help  with  the  tracing  of  (often undiagnosed) infectious  adult  
source cases (25). 
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1.1.4 Childhood TB 
Children become exposed to MTB when they come into contact with an infectious TB 
source case. The risk of becoming infected is determined by the degree of infectiousness of 
the source case, and the closeness and the duration of contact (15).  
Children who get primary MTB infection may not develop active disease; most are 
asymptomatic and do not have any symptoms suggestive of TB. During primary infection 
with MTB, a cell-mediated immune response to the organism develops which is crucial in 
containing the infection in a phase of latency. This is referred to as latent TB infection. TB 
infection can be confirmed by a positive tuberculin skin test (TST), although these tests are 
less sensitive in malnourished or immune compromised children (15, 21).  
MTB infection may progress to TB disease, which may result in considerable morbidity and 
mortality (26). Children who are at risk for progression to active TB disease include infants, 
children under 3 years, malnourished children, those who are immune compromised, 
children not vaccinated with BCG, and those who have recently (within the past two years) 
had their primary exposure to MTB (15). Infants who are HIV-infected have a 20-fold 
higher risk of developing symptomatic TB disease compared to HIV-uninfected infants (15, 
20) 
Children enter a period of relative protection from TB disease between the ages of five and 
ten years. After the age of 10 years, there is an increased risk of TB disease and the nature 
of the disease changes from childhood (primary TB) to adult-type TB (27). TB disease in 
adolescence becomes characteristically that of adult-type PTB (26) where pulmonary 
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cavitation is a common finding. This contributes to the destruction of lung tissue, as well as 
to the spread of infection in the community.   
1.1.4.1 Diagnosis of Childhood TB 
Undiagnosed childhood TB can give rise to considerable morbidity and mortality. 
Unfortunately, TB is difficult to diagnose  in  children  as the signs  and  symptoms of active 
disease are non-specific,  x-rays  are  often  not  diagnostic and isolation of the organism 
may not  be  possible (28).   
Culture-confirmation of TB disease in children is achieved by using whatever specimens 
are available. Clinical samples for the diagnosis of suspected PTB in hospitalised children 
may include gastric aspirates and/or induced sputum, or expectorated sputum from older 
children. For the diagnosis of extrapulmonary TB (EPTB), the organ system involved 
should be targeted for investigation. For example, fine-needle aspiration of enlarged lymph 
nodes, pleural fluid aspiration, joint aspiration, lumbar puncture and biopsies of suspicious 
masses or swellings can be undertaken. Diagnostic yield is greater for culture than 
microscopy because of the paucibacillary nature of childhood PTB (15).  
It is important to note that microbiological specimens are usually obtained from 
hospitalised patients, and are less frequently obtained in the ambulatory setting where 
clinical interaction of the clinician and patient is brief. If the opportunity to investigate an 
ambulatory paediatric TB suspect through the submission of representative clinical 
specimens arises, appropriate specimens (e.g. gastric aspirates, induced sputum, or fine 
needle aspirate of enlarged lymph nodes) from the suspected sites of involvement may be 
obtained for microscopy and mycobacterial culture (29, 30).  
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Gold standard TB diagnosis depends on culture-confirmation of the disease process, with 
less robust TB categorisation representing scenarios in which a greater degree of 
uncertainty regarding the diagnosis arises. Therefore, the diagnosis of TB in ambulatory 
children frequently depends on a poorer degree of evidence as specimens for 
mycobacterial culture are less likely to be submitted (29). Further, limited resources in the 
ambulatory setting are frequently encountered thereby procedures for mycobacterial 
culture are frequently hindered.  Consequently, the clinical history including history of 
contact with an infectious adult source case, clinical examination and results of a few goal-
directed investigations (chest x-ray and/or TST) often form the basis on which a diagnosis 
of TB is made in these children.   
The  decision  to  institute  anti-TB  therapy  in  a  child  is  influenced    by  the  degree  of  
diagnostic  certainty,  potential drug-drug interactions and  the  possible  consequences  of  
failure to start treatment timeously (31). Child and adult TB  mortality  has  been  directly  
linked  to  failure  or  delay  in  diagnosing  the  disease,  or  to  ineffective treatment (2). To  
tackle  this  problem,  WHO  criteria  for  diagnosing  childhood  TB  have  been  
recommended  for  both  clinical  and  epidemiological  purposes. A delayed diagnosis of TB 
can lead to widespread complicated TB disease, e.g. disseminated TB disease, chronic lung 
disease with recurrent co-infections, development of resistant MTB strains, or increased 
TB-related deaths, that are still so commonly found in paediatric wards in South Africa and 
other high-burdened countries. 
Early  identification  of  suspected child TB cases  and  being  able  to  make  a  diagnosis  
early  enough  will  go  a  long  way  in  improving  the  TB-related morbidity and mortality 
in South African children.  
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1.1.4.2 The 1983 WHO Criteria for the Diagnosis of Childhood TB (Appendix 1) 
Culture confirmation of  a  case  of  TB (‘Confirmed’ TB according  to  WHO  criteria)  is  
difficult  in younger children  as gastric aspirates and/or induced or expectorated sputum 
specimens need to be obtained for  microbiological  assessment. Collection of gastric 
aspirates and induced sputum specimens may cause distress to the child. The  finding  of  
acid-alcohol fast bacilli (AFB) on  direct  smear  by  this  method  has  low  sensitivity as 
most childhood PTB is paucibacillary in nature, and low specificity  since  false-positives  
may  be  produced  by  environmental mycobacteria  or  other acid-fast  organisms (32).  
Positive results on direct microscopy should ideally be confirmed by culture. However, 
positive cultures  are  obtained  in  a  minority  of  children,  generally  no  more  than  20-
40% (21, 33).  
Thus  in  children,  the  diagnosis  of  TB  is  made  through  the  combination  of  a  variety  
of  criteria (Appendix 1 and Appendix 2, Box 1), which  include: 
 
a) Clinical  signs and symptoms: 
i. Loss  of  appetite, and/or loss  of  weight; 
ii. Flat growth  curve; 
iii. Weight-for-age  below  the  -2.0  Z-score;   
iv. Failure  to  catch  up  growth  after one month of nutritional support in  a 
malnourished child; 
v. Cough, wheeze or stridor for more than 2-3 weeks;  
vi. Lassitude; 
vii. Intermittent fever. 
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Childhood PTB commonly presents with a progressive, unremitting cough not 
improving on broad-spectrum antibiotics. Duration of the cough is also important, 
with a minimum duration of two weeks. The characteristic cough is more common 
and specific for PTB in children over three years of age (34). PTB can present as 
acute pneumonia in children and so needs to be considered in pneumonia cases not 
responding to conventional forms of treatment (16, 35). The presence of other 
symptoms such as fever, night sweats, weight loss or failure to thrive and fatigue 
will also contribute towards making the diagnosis. Weight loss and/or failure to 
thrive is often associated with TB; a poor response to nutritional support of a 
malnourished child is a sensitive clinical marker of TB or HIV (15).  
 
b)  A history of contact with a source case who has smear- or culture-positive PTB. 
 
A close TB contact is defined as an adult who has had PTB in the last 12 months, 
living in the same household as the child, or someone with whom the child has had 
frequent contact and who is or was sputum smear-positive for AFB (36). Source 
cases that are sputum smear-negative but culture-positive are also infectious, but to 
a lesser degree (15).       
 
c)  The degree of skin reactivity to tuberculin. 
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The TST is a useful tool in providing additional information when assessing a child 
with suspected PTB. It is not a marker of disease activity but, if positive, merely 
indicates infection with MTB (32). Limitations of the TST are seen in HIV-infected 
children who may be unable to mount an immune response to the tuberculin 
derivative, so variable sensitivity is seen (15). Other conditions that may give false 
negative TST results include severe malnutrition, severe TB disease (32), acute viral 
infection (e.g. measles), immunosuppressive therapies, and incorrect administration 
technique or interpretation of the test (36). 
A commonly used TST method is the Mantoux test whereby two units of tuberculin 
purified protein derivative (PPD RT23) are injected intradermally into the volar 
aspect of the left forearm (mid-third). This is read 48-72 hours after administration 
and measured in millimetres (15).   
During the conduct of this study, definitions of Mantoux positivity included: 
 A transverse induration of ≥15 mm in a child vaccinated with BCG (37); 
 Induration of ≥10mm in a BCG-unvaccinated child (37); 
It is these parameters that will be utilised in the study analysis (see Methods 
section). 
Currently and from mid-2000s, a positive TST is defined as: 
 ≥ 10 mm diameter of induration irrespective of BCG immunisation status (36); 
 ≥ 5 mm is considered positive if the child is HIV-infected or severely 
malnourished (36);  
 A negative TST does not rule out infection with MTB. 
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d)  Special investigations, including chest x-ray and collection of appropriate 
specimens for bacteriological confirmation (15).  
 
There are no specific features on clinical examination that can confirm that the presenting 
illness is due to MTB. However, careful clinical examination is necessary to evaluate for 
other systemic focal clinical signs, e.g. asymmetrical lymphadenopathy indicating TB 
adenitis, distended abdomen and ascites indicating abdominal or peritoneal TB, decreased 
level of consciousness indicating TB meningitis, asymmetrical joint effusion indicating TB 
of the joint, or gibbus indicating spinal TB. 
Since  young  children,  especially  those  under  the  age  of  two years,  are  prone  to  
develop  disseminated  disease  after  primary  MTB infection (38),  clinicians  generally  
feel  compelled  to  initiate  anti-TB  therapy  upon  what may seem to be rather scant 
evidence (39). A  plea  has  been  made  for  the  use  of  a  uniform  set  of  diagnostic  
criteria  for  childhood  TB (6,40).          
WHO  has  suggested  a  graduated  approach  to  improve  the  degree of certainty  with  
which  the  diagnosis  of  childhood  TB  is  made.  Cases are classified as ‘Suspect’, 
‘Probable’, or ‘Confirmed’ TB (7), in a manner similar to that recommended by the WHO in 
1983 (41).  
 
Suspect TB (7,41) 
1. An  ill child  with  a  history  of  contact  with  a  confirmed  case of PTB; or              
 
2. Any  child: 
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 Not regaining normal health after measles or whooping cough; and/or 
 With loss of weight, cough and wheeze not responding to antibiotic therapy for 
respiratory disease; and/or 
 Painless swelling in a group of superficial nodes. 
 
 
Probable TB (7,41) 
A child with probable TB would be classified as such if any of the following factors are 
identified: 
 Positive induration on Mantoux TST (41); 
 Suggestive appearance on chest x-ray; 
 Suggestive histologic appearance of biopsy material; 
 Favourable response to specific anti-tuberculous therapy. 
 
Confirmed TB (7,41) 
 Detection by microscopy or culture of AFB from secretions or tissues; and/or 
 The identification of the organism as MTB by culture characteristics. 
 
As a  high  degree  of  suspicion  is  necessary  to  diagnose  TB  in  childhood, it  is  important  
to  know  how  much  reliance  can  be  placed  on  criteria  being  used  to  diagnose  and  
notify  TB  cases. 
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1.2 STUDY AIMS    
AIM: To compare and contrast the criteria used to diagnose childhood TB at two paediatric 
outpatient departments in Johannesburg between 01 November 1997 and 30 June 1998 
and to compare these criteria to those used by the World Health Organisation in the 
diagnosis of TB (41). 
We tested the hypothesis that there is no difference between the criteria used to diagnose 
TB in children between the ages of three months and fourteen years at Coronation and 
Johannesburg General Hospital when compared to the criteria used by the WHO to 
diagnose TB.    
 
1.2.1 The objectives of the study were to:  
 
a) To compare and contrast   criteria  being  used  to  diagnose and notify TB  in two 
paediatric  outpatient  departments  in  Johannesburg between 01 November 1997 
and 30 June 1998. 
 
b) To determine  whether  the  criteria  being  used  in  the  two  outpatient 
departments are comparable with the criteria used by the WHO to diagnose TB(41). 
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c) To identify whether any differences exist between the criteria being used between 
the two paediatric outpatient departments and those of the WHO in the diagnosis of 
TB. 
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Chapter 2: Methods 
Chapter Summary 
This chapter defines the study cohort, baseline characteristics and the clinical and non-
clinical variables used to determine the diagnosis of TB disease in the patient cohort. A 
description of the statistical analysis is also included in this chapter.       
 
2.1 METHODS  
This was an observational, descriptive, retrospective, hospital outpatient-based study. The 
setting was in two academic hospital paediatric outpatient departments, namely 
Coronation Hospital (now known as the Raheema Moosa Mother and Child Hospital 
(RMMCH)) and Johannesburg General Hospital (now known as the Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH)) in Johannesburg, South Africa. All children 
ranging from the ages of 3 months to 14 years, who attended the paediatric outpatient 
departments in the two academic hospitals, between 01 November 1997 and 30 June 1998, 
and were diagnosed and notified as having TB in these outpatient settings, comprised the 
study population.    
The study cohort was identified by review of notification booklets completed by paediatric 
outpatient staff members.  This approach may have led to the unanticipated outcome of 
missing some children diagnosed with TB but who were not notified for their condition.  
Identification of subjects from notification booklets was conducted on a weekly basis from 
each paediatric outpatient department, throughout the eight-month research period. Hospital 
folders were reviewed by retrieval of the records from hospital archiving departments. 
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Criteria used to establish the diagnosis of TB for each patient were identified by data 
abstraction from case hospital records.  Data were abstracted onto a standardised 
abstraction sheet (Appendix 3), and included: clinical history, focussing on symptoms 
suggestive of symptomatic TB disease (e.g. fever, cough and duration, loss of appetite, weight 
loss, night sweats, neck swellings); history of contact with an adult PTB case; clinical details 
including age, gender, weight (in kilograms) at the time of notification, results of TST (the 
intradermal Mantoux test), chest x-ray findings, and results of microscopy and culture of 
sputum, gastric aspirates or other specimens.  
Interpretation of the Mantoux skin test at the time the study was conducted was different 
to how it is currently being interpreted, and we therefore used the TST grading system 
used by clinicians working at the outpatient department at CH and JGH in 1997/98 (listed 
below) as this interpretation guided their clinical decision making. The interpretation was 
defined as:  
 Positive if the transverse induration was ≥15mm in a child vaccinated with BCG 
(37); 
 Positive if the induration was  ≥10mm in a BCG-unvaccinated child (37);  
 Negative if the induration was 5-10mm which may have indicated infection with 
MTB, or be a result of recent BCG immunisation (within the last two years) (42), or 
infection with a non-tuberculous mycobacterium (42).  
 Negative if the induration was <5 mm; this would either suggest that there was no 
TB, or that the child had a sub-optimal immune response to tuberculin in spite of 
active infection with the MTB (i.e., a false negative result) (42).  
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HIV tests were not sought as part of this study as the majority of participants did not routinely 
have an HIV test done in the late 1990s. 
 
2.1.1 Study Sample Size 
An estimate as to the number of children who would be diagnosed during the study time 
frame was made by interrogating the number of children notified as having TB at the 
paediatric outpatient department of CH between 01 January and 31 July 1997. During that 
seven-month time period, 42 children (i.e. six children per month) had an outpatient-based 
diagnosis of TB. It was therefore anticipated that approximately 50 children would be 
diagnosed with TB at each of the study hospital outpatient departments during the eight-
month study period.  
 
2.1.2 Statistical Methods 
Data were captured manually and then entered into a personal computer using Excel 
software (Microsoft Corporation, Seattle, USA) and analysed in Excel and Stata version 12.0 
(StataCorp, College Station, Texas, USA), with the assistance of a statistician (Mr Alfred 
Musekiwa) from the Wits Reproductive Health Institute (WRHI). 
Dichotomous outcomes were analysed using frequencies and proportions (percentages), 
and were represented in bar charts and pie charts. Pearson’s Chi-squared test (or Fisher’s 
exact test where appropriate) were used to compare proportions of children evaluated 
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using different diagnostic methodologies at each of the paediatric outpatient settings, and 
P-values <0.05 were considered to be statistically significant; P-values were derived using 
Stata version 12.0 (StataCorp, College Station, Texas, USA). 
 
Continuous variables with normal distributions were summarised using the mean and 
standard deviations, while those with skewed distributions were summarised using the 
median and interquartile ranges. Means were compared using the Student’s t test and 
medians were compared using the two-sample Wilcoxon rank-sum test. Weight-for-age Z-
scores (WAZ) were derived using WHO AnthroPlus software, version 1.0.4 (WHO, Geneva, 
Switzerland). 
 
Microsoft Excel was used for the calculation of frequencies, percentages, means, SDs, 
medians, and ranges. Excel was also used for the construction of bar charts, histograms and 
pie charts.  
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Chapter 3: Results 
Chapter Summary 
This chapter describes results of the statistical analysis of all the indicators examined, with 
comparisons of results from the two hospitals with the criteria used by the WHO to 
diagnose TB. Clinical histories and baseline clinical characteristics of the study participants 
are described. Graphic representations of baseline characteristics are also demonstrated in 
this chapter.  
 
3.1 RESULTS 
3.1.1 Clinical characteristics of children diagnosed with TB at the two Outpatient 
Departments 
One hundred and one children were diagnosed with TB in the outpatient departments at the 
two hospitals during the eight month study period. Folders for each of these children were 
retrievable from the hospital records departments. Features on clinical history that were 
enquired about as part of the clinicians’ evaluation for TB at both outpatient departments 
are summarised below (Table 3.1 and Figure 3.1).   
The combination of symptoms suggestive of active TB, which included persistent cough >1 
month with fever, associated with loss of weight and loss of appetite, was more common in 
the JGH cohort (32 of 51 patients; 63%) compared to the CH cohort where only 10 of 50 
patients (20%) had this combination of symptoms and signs; Odds Ratio (OR) 6.74 (95% 
Confidence Interval (CI), 2.54-18.41), P<0.001 (Figure 3.1).  
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Table 3.1:  Clinical Characteristics of Children Diagnosed with TB at CH and JGH Paediatric 
Outpatient Departments 
 
Clinical History      CH 
(N=50; %) 
  JGH 
(N=51; %) 
CH + JGH 
(N=101; %) 
Odds Ratio  
(95% CI) 
P-
value 
Fever 1 (2) 0 1 (1) - 0.243# 
Weight Loss (WL) / 
Loss of appetite (LOA) 
4 (8) 1 (2) 5 (5) 4.35  
(0.41-218.28) 
0.205# 
Upper Respiratory 
Tract Infection 
(URTI) 
10 (20) 4 (8) 14 (14) 2.88  
(0.75-13.41) 
0.084 
URTI + WL + LOA + 
Fever 
14 (28) 11 (22) 25 (25) 1.41  
(0.52-3.92) 
0.454 
Cough > 1 month 7 (14) 1 (2) 8 (8) 8.14  
(0.97-373.95) 
0.031# 
Cough > 1 month + 
WL + LOA + Fever 
10 (20) 32 (63) 42 (42) 0.15  
(0.05-0.39) 
<0.001 
Neck Swellings (NS) 2 (4) 1 (2) 3 (3) 2.08  
(0.10-125.32) 
0.618# 
NS + WL + LOA + 
Fever 
2 (4) 1 (2) 3 (3) 2.08  
(0.10-125.32) 
0.618# 
Total 50 (100) 51 (100) 101 (100) - - 
 
WL = Weight loss; LOA = Loss of Appetite; URTI = Upper Respiratory Tract Infection; NS = Neck 
Swellings.  
# Fisher’s exact test. 
 
Few patients presented with cough of greater than one month’s duration alone: CH had seven 
such children in their cohort, and JGH had only one in their cohort.   
Cervical tuberculous adenopathy was typically described as ‘neck swellings’ by clinicians in 
both outpatient departments: this presentation was uncommon in both cohorts with CH 
having two such patients and JGH having only one. 
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Figure 3.1: Comparison of Clinical Characteristics of patients at CH(RMMCH) & JGH(CMJAH)   
WL = Weight loss; LOA = Loss of Appetite; URTI = Upper Respiratory Tract Infection; mth = Month; 
NS = Neck Swellings; RMMCH = CH; CMJAH = JGH 
* P-value < 0.05 
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A presentation of fever alone was found in one patient from the CH outpatient clinic. No 
patients presented with fever alone in the JGH outpatient department.  
3.1.2 Baseline Clinical Characteristics    
Clinical parameters that were extracted from clinical notes and analysed included: age, 
gender, weight (in kilograms), history of TB contact, presenting symptoms, TST results, x-
ray and microbiology (MTB smear and culture) results (Table 3.2). 
3.1.2.1 Age Range of Children Diagnosed with TB in the Ambulatory Setting 
The median age of the 101 TB-notified children was 24 months (Interquartile Range [IQR], 
14-42 months), and did not differ significantly between hospitals, P=0.741 (Wilcoxon rank-
sum test). Both cohorts presented a skewed age distribution with the majority (36%) of 
children lying in the <12 month age group at CH (Figure 3.2). At JGH, the majority (51%) of 
children were in the 13-24 month age group (Figure 3.3). 
3.1.2.2 Gender Distribution 
There was a slight male predominance in children diagnosed with TB on an outpatient 
basis, with 26 of 50 (52%) and 29 of 51 (57%) male children in the CH and JGH cohorts, 
respectively (Figures 3.4 and 3.5). 
3.1.2.3 Weight at Time of TB Diagnosis 
Weight-for-age data at time of TB diagnosis were available for 99 (98%) of the 101 
children. The mean WAZ was -0.647 (Standard Deviation [SD] 1.25) amongst children 
managed through CH, and -0.273 (SD 0.970) amongst those managed at JGH, P=0.100. 
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Table 3.2: Demographic and Diagnostic Characteristics of Children Diagnosed with TB at CH 
and JGH Paediatric Outpatient Departments   
Baseline 
Characteristic 
CH  
(N=50) 
 
JGH  
(N=51) 
 
P-values CH & JGH  
(N=101) 
AGE (months), 
Median (IQR) 
24 (10-52) 24 (16-36) 0.741^ 24 (14-42) 
SEX, N (%) 
Female 
Male 
 
24 (48) 
26 (52) 
 
22 (43) 
29 (57) 
 
0.624* 
 
46 (45.5) 
55 (54.5) 
TB CONTACT,  
N(%) 
Positive TB contact 
No known TB 
contact 
 
 
17 (34) 
33 (66) 
 
 
15 (29) 
36 (71) 
 
 
0.620* 
 
 
32 (31.68) 
69 (68.32) 
TST, N (%) 
Done/Positive 
Done/Negative 
Not Done 
 
44 (88) 
4  (8) 
2  (4) 
 
43 (84) 
0  (0) 
8  (16) 
 
0.592*  
 
0.092# 
 
87 (86.2) 
4  (3.9) 
10 (9.9) 
RADIOLOGY, N (%) 
Suggestive 
Not Done 
LRTI 
Normal 
 
33 (66) 
9  (18) 
6  (12) 
2  (4) 
 
19 (37) 
6  (12) 
0  (0) 
26 (51) 
 
0.004*  
 
52 (51.5) 
15 (14.8) 
6  (5.9) 
28 (27.8) 
MICROBIOLOGY, N 
(%) 
Done/Positive 
Done/Negative 
Not Done 
 
 
 
2  (4) 
2  (4) 
46 (92) 
 
 
1 (2) 
0 (0) 
50 (98) 
 
 
0.205# 
(Comparison 
of proportion 
of cases that 
were 
investigated by 
means of 
submission of 
specimens at 
each hospital) 
 
 
3  (3) 
2  (2) 
96 (95) 
 
CH = Coronation Hospital; JGH = Johannesburg General Hospital; TB = Tuberculosis; TST = 
tuberculin skin test; LRTI = Lower respiratory tract infection; Microbiology = sputum/gastric 
aspirate cultures.  
 
^ Wilcoxon rank-sum test.  
* Chi-square test.  
# Fisher’s exact test. 
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Figure 3.2: Age Distribution (CH) 
 
 
         Figure 3.3: Age Distribution (JGH) 
 
 
Figure 3.4: Gender Distribution (CH)  
 
Figure 3.5: Gender Distribution (JGH)  
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The weight-for-age distribution (comparing WAZ distributions) in children with an 
outpatient TB diagnosis was similar at the two hospitals (Figure 3.6). CH had 53% (26/49) 
of the cohort lying between the -2 and 0 WAZ (Figure 3.7), and JGH had 54% (27/50) of the 
cohort lying between the -2 and 0 WAZ (Figure 3.8). Both hospitals also showed a similar 
distribution in their cohorts of patients lying above the 0 WAZ (median) line: CH, 33% 
(16/49); JGH, 38% (19/50), P=0.578. 
 
Figure 3.6: Weight-for-age Z-score distribution for CH and JGH  
 
CH (n=49) JGH (n=50) 
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Figure 3.7: Weight-for-Age Distribution (CH) 
 
 
  
Figure 3.8: Weight-for-Age Distribution (JGH) 
 
 
< -3
> -3
> -2
0 (Median
Line)
>0
0
20
40
60
2
10
53
2
33
Fr
eq
u
en
cy
WAZ Categorisation
Weight for Age Distribution (WAZ Categorisation) - CH  
< -3
> -3
> -2
0 (Median
Line)
>0
0
20
40
60
2
4
54
2
38
Fr
eq
u
en
cy
WAZ Categorisation
Weight for Age Distribution (WAZ Categorisation) - JGH
27 
 
3.1.2.4 TB Exposure History 
Almost one third (32/101; 32%) of the children had a positive TB exposure history, and 
this trend was seen at both hospitals, with 34% (17/50) having a positive TB contact at CH 
(Figure 3.9) and 29% (15/51) at JGH (Figure 3.10). Details as to who the TB contacts were, 
were not readily available from the hospital notes. 
 
Figure 3.9: Proportion of Cases with History                   Figure 3.10: Proportion of Cases 
 of TB Contact (CH)                                                                       with History of TB Contact (JGH)                 
             
Although numbers were too small to derive statistical significance from the analyses, the 
majority (35%) of children with a positive TB contact were older than 60 months of age at 
CH whereas nearly half (47%) of those with a positive TB contact were in the 24 to 59 
months age category at JGH (Table 3.3). 
Combining the two cohorts, the majority (38%) of children with a positive TB contact were 
in the 24 to 59 month age group and three quarters of the children with a positive TB 
contact were under 60 months of age (Table 3.3).  
34%
66%
TB Contact - CH 
Positive Negative
29%
71%
TB Contact - JGH
Positive Negative
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Table 3.3: Comparison of Age Ranges with TB Contacts at CH and JGH  
 
                          CH 
                     (N = 50) 
                          JGH 
                         (N = 51) 
P-value       CH + JGH 
          (N  = 32)  
AGE 
(Months) 
TB Contact – 
Positive 
N (%) 
TB Contact – 
Negative 
N (%) 
TB Contact – 
Positive 
N (%) 
TB Contact – 
Negative 
N (%) 
TB Contact 
–  
Positive 
 
   TB Contact –  
    Positive 
    N (%) 
0 - 11 4 (24) 13 (39) 3 (20) 1 (3) 0.088#           7 (22) 
12 - 23  2 (12) 4 (12) 3 (20) 16 (44) 0.562#           5 (16) 
24 - 59 5 (29) 12 (36) 7 (47) 18 (50) 1.000#           12 (38) 
> 60 6 (35) 4 (12) 2 (13) 1 (3) 1.000#           8 (25) 
Total (N)   17 (100) 33 (100) 15 (100) 36 (100) -           32 (100) 
 
# Fisher’s exact test 
 
3.1.2.5 TST Reactivity amongst Children Diagnosed with TB as Outpatients
Using the Mantoux cut-off interpretation outlined by the 1983 WHO Child TB Diagnostic 
Guidelines (41,37) which would have been used by the staff at the outpatient departments 
at the time of conduct of this study, TST reactions were positive in 86% of the total cohort, 
with a similar result being seen at both hospitals; CH having 88% of participants with a 
positive TST (Figure 3.11) and JGH having 84% participants with a positive TST (Figure 
3.12).  
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Figure 3.11: TST Results (CH) 
 
                  Figure 3.12: TST Results (JGH) 
                                                     
The median age of children with a positive TST reaction was 24 months (IQR 14-48 
months), and was not significantly different at each hospital, P=0.926. Children with a 
history of positive TB contact had larger TST reactions (median transverse induration 
20mm, Range 10-28mm) compared to those who did not have a TB contact (median 
transverse induration 16mm, Range 0-30mm), P=0.0343. 
 
 
3.1.2.6 Chest X-ray Findings in Children Diagnosed with TB as Outpatients 
Two thirds of the children diagnosed with TB at CH had chest x-ray features suggestive of 
TB (Figure 3.13), whereas only 37% had x-ray features at JGH (Figure 3.14), P=0.004 
(Table 3.2). Patient records did not specify if lateral films were taken. The CXR 
88%
8% 4%
TST - CH
Done/positive Done/negative Not done
84%
0%
16%
TST - JGH
Done/positive Done/negative Not done
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interpretations were based on the clinician notes which did not draw the distinction 
between AP and lateral films. Both outpatient departments showed a similar percentage of 
x-rays not being done as part of their investigations in diagnosing TB (CH, 18%; 
JGH, 12%).  
 
Figure 3.13: Radiology Results (CH)                          Figure 3.14: Radiology Results (JGH) 
 
LRTI = lower respiratory tract infection, a radiographic feature that was attributed in children 
notified for tuberculosis, but whose x-ray findings were not suggestive of PTB. 
Suggestive  = Persistent opacification with enlarged perihilar lymph nodes. 
 
3.1.2.7 Microbiology Specimen Submission Practice at the Two Hospital Outpatient 
Departments 
Submission of specimens for microbiological assessment was not a common practice in 
either outpatient department, with 95% (96/101) participants not having any specimens 
37%
12%0%
51%
Radiology - JGH 
Suggestive Not Done LRTI Normal
66%
18%
12% 4%
Radiology - CH
Suggestive Not Done LRTI Normal
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collected. Ninety-two percent (46/50) of participants did not have any specimens collected 
at CH (Figure 3.15), as did ninety-eight percent (50/51) participants from JGH (Figure 3.16).  
      
                
  
 
 
 
 
Figure 3.15: Microbiology Results (CH)  
 
 
 
 
 
 
 
 
Figure 3.16: Microbiology Results (JGH) 
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3.1.3 WHO Classification of TB in the study cohort 
Sixty five percent (33/51) of the children evaluated at JGH were notified for TB using five of 
the seven criteria (i.e., weight loss; chronic cough; neck swellings; TB contact history; TST; 
chest x-ray; submission of specimens for mycobacterial culture) recommended by the 1983 
WHO Child TB Diagnosis algorithm, whereas 82% of the children notified for TB at CH had 
their diagnosis based on six or seven criteria, P<0.001 (Table 3.4). 
Table 3.4: Number of Criteria Used to Make a Diagnosis of TB at CH and JGH 
Paediatric Outpatient Departments 
Number of Criteria 
Used in the TB 
Work-up 
CH  
N (%) 
JGH  
N (%) 
P-value 
Five 9 (18) 33 (65) <0.001 
Six 39 (78) 18 (35) <0.001 
Seven 2 (4) 0 - 
Total 50 (100) 51 (100)  
  
The majority of the children diagnosed with TB at both outpatient settings had a clinical 
presentation of ‘Probable’ TB. CH had 90% (45/50) of their TB patients classified as 
‘Probable’ TB (Figure 3.17), and JGH 96% (49/51) (Table 3.5). ‘Confirmed’ TB contributed 
very low percentage of the cohort in both outpatient departments where microbiological 
specimen submission was not a common practice; CH only had two (4%) confirmed cases 
and JGH had 1 (2%) confirmed case (Table 3.5). 
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Table 3.5: WHO Classification of TB Outcomes for Children Diagnosed with TB at CH 
and JGH Paediatric Outpatient Departments 
TB Category   CH 
 (N=50; %) 
JGH  
(N=51; %) 
CH + JGH 
(N=101; %) 
 
Odds Ratio 
(95% CI) 
P-value 
Suspect TB 3 (6) 1 (2) 4 (4) 3.19  
(0.24-170.81) 
0.362# 
Probable TB 45 (90) 49 (96) 94 (93) 0.37 
(0.03-2.40) 
0.269# 
Confirmed 
TB 
2 (4) 1 (2) 3 (3) 2.08  
(0.10-125.32) 
0.618# 
 
# Fisher’s exact test. 
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                                                      Chapter 4: Discussion and Conclusion 
 
This was a retrospective, hospital outpatient-based observational study, conducted in two 
ambulatory paediatric settings in Johannesburg. Patients ranging from the ages of three months to 
14 years, who attended the paediatric outpatient departments in the two academic hospitals 
between 01 November 1997 and 30 June 1998, and were diagnosed and notified as having TB in 
these outpatient settings, comprised the study population. A total of 101 patients were included in 
the research study; 50 patients from CH and 51 patients from JGH.    
4.1 Baseline Clinical Characteristics 
 
4.1.1 Age at TB Diagnosis 
The results demonstrate that most (50%) children who presented to the two outpatient 
departments and were diagnosed and notified as having TB were in the under 24 month 
age group. This is comparable with the demographics of a prospective community based 
study conducted in two suburbs of Cape Town, where 35.8% of children were <2 years 
(43). The annual risk of TB infection (ARI) is not constant across all ages (44); there are 
specific age periods when TB infection rates increase (45), and these age periods seem to 
correlate with times of widening social contact (44). Most children who become infected 
with MTB before two years of age are infected by a household source case (44). Additional 
caregivers outside the household are also important, especially domestic workers, 
grandparents or extended family members who take care of the children during the day, if 
both parents are working. Primary infection occurs at a younger age in high-density, low 
income urban areas (44) as is the case with the feeder communities for CH and JGH. 
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Children who are infected with MTB before the age of two years frequently progress to 
active TB disease within the first twelve months without significant prior symptoms (46).  
4.1.2 Gender Distribution among TB Cases        
Gender distribution was similar in both hospitals with both CH and JGH showing a slight 
male predominance – CH, 52% (Figure 3.4); JGH, 57% (Figure 3.5). The male-to-female 
ratio for both hospitals is 1.2:1, similar to that observed in a retrospective study carried out 
in Parrow, Cape Town in 1987, which looked at the criteria used for the notification of 
childhood TB; boys were more affected than girls with the male-to-female ratio of the 
children being 1:0.3 (39); 46% percent of the children were < 2 years of age (39) which 
also compares well with this study where 51% of the children in the JGH cohort were in the 
13–24 month age group (Figure 3.3).  
Globally, the prevalence of infection with MTB is similar in males and females in children 
until adolescence, after which it is higher in males (47).  
4.1.3 Nutritional Status of TB Cases 
The weight-for-age distribution (comparing their WAZ distributions) in children with an 
outpatient TB diagnosis was similar at the two hospitals: 53% and 54% of the cohort 
plotted between the -2 and the 0 weight-for-age Z-score, at CH and JGH, respectively 
(Figures 3.7 and 3.8). Both hospitals also showed a similar distribution in their cohorts of 
patients lying above the 0 Z-score (median) line: CH, 33%; JGH, 38%. The nutritional status 
of the two cohorts is a reflection of a community that is able to provide sufficient 
nutritional requirements for their children. It would be expected to have a relatively better 
nourished cohort in children diagnosed with TB in the outpatient setting.     
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Childhood TB is usually associated with weight loss and/or failure to thrive (15); 
malnutrition may predispose to TB, and TB can in turn cause malnutrition (48). Regular 
documentation of weight becomes an invaluable tool in children suspected of having TB, as 
a child with TB will generally not thrive (15). A poor response to nutritional support of a 
malnourished child is a clinical marker of TB or HIV (15).  
The degree of malnutrition has also been found to have an impact on the morbidity and 
mortality of patients diagnosed with TB (48). Poor nutrition has been found to increase the 
risk of early primary TB infection, disseminated TB disease and repeated infection with 
MTB (49). In a study conducted in a rural district in Malawi between 1999 and 2001, 
Zachariah et al were able to conclude that higher rates of early death occurred in patients 
with moderate to severe malnutrition, compared to those whose nutritional status was 
normal or mildly impaired; these differences were found regardless of age or HIV 
serostatus (48).    
4.1.4 TB Exposure History         
The majority of children evaluated in this study were in the under 24 month age group, and 
the median age of those with a positive TST was also 24 months; this strongly suggests that 
these children had a close family contact with TB. Furthermore, three quarters of the 
children with a positive TB contact history were under 5 years of age (Table 3.3), and those 
with a positive TB contact were more likely to have a strongly positive TST response. 
Although all children included in this study had TB exposure history recorded in their 
clinical notes, a positive exposure was surprisingly low in both cohorts: 68% of the total 
cohort gave a negative history of TB contact. This may reflect a large proportion of 
undiagnosed TB contacts in the adult population where these children have come from. 
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Unknown TB contacts contribute to the diagnostic uncertainty and difficulty in diagnosing 
TB in children where the signs and symptoms of active disease are non-specific. Early 
identification and diagnosis of adult source cases is crucial in preventing childhood TB 
infection and early identification of suspected child TB cases would be expected to improve 
the TB-related morbidity and mortality in children (6).  
TB often carries a negative stigma in areas of high prevalence and a direct enquiry into a 
family history of TB may often be denied as was the case in a study carried out in a rural 
hospital in Kenya between 1981 to 1983, in which 144 children were studied and only 34 
(24%) had a positive history of a TB contact in the family (49).  
Healthcare workers have also been found to contribute to delay in diagnosis of childhood 
TB by failing to enquire about the presence of TB amongst close household adult contacts 
(6).  
It must be noted that MTB infection may occur without known exposure and the absence of 
a potential source case does not exclude TB (50). Young children usually become infected 
after exposure to a sputum smear–positive household contact. Sputum smear–negative 
contacts generally are less infectious but may still infect children (50), for example in a low 
burdened TB setting in the Netherlands, adults with smear-negative, culture positive TB 
were responsible for 13% of TB transmission (51).   
WHO and the IUATLD have recommended that contact tracing is a valuable means of 
identifying new TB cases (36), and this would be expected to impact substantially on TB 
infection control. Contact tracing has been advocated by the South African National 
Department of Health in 2009 as part of the National TB Management Guidelines (52). 
Emphasis is placed on contact tracing and case detection, increasing awareness amongst 
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communities on TB infection control, and integrating this programme into the District 
Primary Health Care system so as to ensure early TB case detection.  
Contact tracing is a process whereby individuals in contact with a case of confirmed or 
suspected PTB are screened for the presence of TB infection or disease, with the aim of 
offering either INH preventive therapy or anti-TB chemotherapy to those who qualify for 
such management (50). In the event of a child being diagnosed with TB disease, reverse 
contact tracing should be adopted, and potential source cases from the home environment 
are sought by symptom screening and/or chest radiography (50).  
Unfortunately, the widespread implementation of contact tracing activities in over-
burdened TB Control Programs is often hampered because activities are focussed on 
treating the current TB case load (36). The adequacy of contact tracing activities within the 
context of the South African TB Program would be expected to be compromised due to the 
current patient load (296,996 new TB cases, 38,578 [13%] of whom were children under 
15 years of age, were treated by the South African TB Programme in 2012) (11). 
4.1.5 Mantoux Responses      
The TST used in both outpatient departments was the Mantoux test. The Mantoux test 
remains the skin test of choice for diagnosing TB infection (53). CH paediatric outpatient 
department had a better record of the procedure being done, with 96% of their cohort 
receiving a Mantoux test. JGH only did the test on 84% of their cohort, all having a positive 
result (Table 3.2).   
The young age at TB diagnosis (based on the finding of five criteria out of the seven (See 
Section 3.1.3)) in this cohort (median age of 24 months was found in the children with a 
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positive TST reaction), may suggest that the majority of these TB cases had a close family 
contact with TB.  
 In the revised recommendations of the WHO, a positive (or ‘reactive’) Mantoux skin test is 
defined as a transverse induration of  ≥10 mm when read 48–72 hours after 
administration, irrespective of BCG immunisation status, or ≥5 mm if the child is HIV-
infected or severely malnourished (36). 
Prior to the early 2000s, at the time in which this study was conducted, interpretation of 
the Mantoux skin test was different (please refer to Sections 1.1.4.2 and 2.1 of this 
dissertation for details of the previous interpretation system)(37).  We used the latter 
Mantoux classification system in attributing Mantoux positivity in the study cohort, as this 
was what was used by clinicians diagnosing childhood TB in the outpatient departments 
described in this study. 
Changes in interpretation of the Mantoux skin test, using a positive cut-off of 10mm 
regardless of BCG vaccination status and 5mm in HIV-infected children, came about 
because of the changes in epidemiology of TB and its influence on skin testing; appropriate 
cut-off points for a positive reaction among different groups were re–classified(53). The 
impact of HIV infection on TST responses played a major role in dictating the revision in 
interpretation of Mantoux induration, and it remains important to interpret the TST in the 
context of the underlying nutritional status of the patient(54).  
TST is more likely to be negative in children with severe malnutrition and/or with 
advanced immune suppression as they are unable to mount an immune response against 
tuberculin (15). We presume that, due to the high prevalence of positive Mantoux 
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responses in this cohort of children being diagnosed with TB infection in the study 
outpatient settings in the late 1990s, the majority of these cases were most likely HIV-
uninfected and of a relatively good nutritional status. HIV-infected children who are long 
term survivors or ‘slow progressors’ may not become symptomatic until beyond two years 
of age, and may have accounted for a sub-set of the children with positive Mantoux 
responses in our cohort. TST is less sensitive in HIV-infected children than in HIV-
uninfected (15) and variable sensitivity remains a major limitation of TST in the diagnosis 
of TB in HIV-infected children (15). It would have been helpful to have obtained HIV results 
in all of the children to test this conjecture. 
4.1.5.1 Lack of HIV Test Results in the Study Cohort 
HIV testing was not done routinely in these two paediatric outpatient settings; this could 
have been as a result of the low HIV serostatus prevalence at the time of conduct of this 
study. A study conducted at the Chris Hani Baragwanath Academic Hospital between 1992 
to 1996, looking at the impact of increases in HIV infection in hospitalised children, found 
only 120 (3%) children infected out of 3,800 admitted in 1992 (55). By 1996, the number 
of HIV infected children had risen to 870 (19%) out of 4,694 admitted. HIV infection 
prevalence would be expected to be lower in children assessed in the ambulatory setting, 
i.e. those who were not ‘ill enough’ to warrant hospitalisation.  
Paediatric ART coverage was low in the late 1990s, with 83% of eligible children not being 
able to access ART (56), and the South African National ARV roll-out only commenced in 
April 2004.  
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These factors may have contributed to medical officers not routinely doing HIV testing in 
patients presenting to the outpatient departments in the late 1990s.  
4.1.6 Chest X-rays in the Outpatient Diagnosis of Paediatric TB      
The chest x-ray findings recorded for the children diagnosed and notified as having TB in 
the two outpatient departments was either ‘suggestive’ of TB (hilar lymphadenopathy, 
cavitation, miliary picture), a ‘lower respiratory tract infection’ (bronchopneumonia, 
pneumonia) or ‘normal’. A small percentage (15%) of children evaluated for TB in both 
outpatient departments did not have a chest x-ray done as part of their investigations. Two 
thirds of the children diagnosed with TB at CH had x-ray features suggestive of TB (Fig. 
3.13), whereas only 37% had x-ray features at JGH (Fig. 3.14), P=0.004 (Table 3.2). No 
children were diagnosed with a lower respiratory tract infection on x-ray in the JGH 
outpatient setting, and more children evaluated there (51%) had normal chest x-rays 
compared to children seen at CH (Table 3.2). By contrast, 12% of the children diagnosed 
with TB at the CH outpatient department had features of ‘lower respiratory tract infection’ 
on their x-ray and only 4% of the CH cohort had normal chest x-rays. This could be a 
reflection of the radiology experience of the medical officers in both outpatient 
departments and possible closer collaboration between radiologists and outpatient staff at 
CH where it is evident that a radiologic diagnosis of PTB was more frequently made than at 
JGH. Radiological findings in PTB may not always help towards the diagnosis, particularly 
in small children, and can at times be confusing (57).  
Interpretation of chest radiographs is a process marked by inconsistencies among different 
readers and between the opinions of the same reader on different occasions (7). Hilar 
lymphadenopathy may be difficult to detect on the antero-posterior chest radiograph and 
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this forms part of the radiological criteria for the diagnosis of childhood TB (39). Cavity 
formation is unusual in young children and more common in older children or adolescents 
(15). Cavities on chest x-ray are more common in HIV-infected children than in HIV un-
infected children (54).  
Despite the limitations of chest radiography as mentioned above, chest x-ray remains an 
important diagnostic tool for PTB in young children (15), and may be the only diagnostic 
tool in many settings (15), because obtaining specimens for microbiological assessment 
and confirmation outside tertiary referral centres remains a difficult task. A publication of a 
cross-sectional study carried out in Malawi in 2002, in 44 non-private hospitals that 
register and treat children with TB, reported that the diagnosis of PTB was based mainly on 
clinical features and radiography; less than 10% had TSTs done, or HIV serology (58).  
With the rising TB/HIV epidemic, differentiating TB from HIV–related lung disease (e.g. 
Pneumocystis jirovecii pneumonia and lymphoid interstitial pneumonitis) has become a 
common diagnostic challenge in HIV–endemic regions (15). HIV–related lung disease and 
TB may co-exist and have many similar features (16), thus a high index of suspicion has 
become imperative to make the diagnosis of PTB (16) and this advocates further for 
improved specimen collection and submission for the confirmation of PTB; hence 
microscopy and microbiological culture evaluation should become an important part of 
clinical practice in the diagnosis of TB, even in the ambulatory setting.  
4.1.7 TB Microbiologic Testing 
Submission of specimens for microbiological assessment was not a common practice in 
both outpatient departments, with 95% of participants not having any specimens collected. 
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This could be as a result of the non-specific presentations that are commonly seen in the 
ambulatory environment and the difficulty in obtaining specimens for microbiology in 
children accessing the ambulatory health care setting. 
Bacteriological confirmation of PTB is rarely achieved in resource–limited settings where 
most cases present, and where mycobacterial culture infrastructure is limited (15). WHO 
advises the confirmation of the diagnosis of TB in children by using whatever specimens and 
laboratory facilities are available (36). Appropriate specimens should be submitted for 
microscopy and for mycobacterial culture and histopathological examination from the TB-
affected sites where laboratory facilities permit. Appropriate clinical specimens may include 
expectorated or induced sputum, gastric aspirates, fine needle aspiration, lymph node biopsy 
or any other specimen that is biopsied (Appendix 2, Box 2).  
A prospective study carried out in a primary health care facility in Cape Town between 
March 2007 and June 2009 demonstrated the feasibility of sputum induction for the 
diagnosis of TB in children in a community setting. Eleven percent of child participants had 
positive TB microbiology (smear- and/or culture-positive) (29), a yield similar to that 
observed in adult TB suspects. The same study demonstrated that TB microbiologic testing 
can in fact enhance the certainty of the TB diagnosis: 17% of children with ‘Probable’ TB at 
initial evaluation were confirmed microbiologically. Microbiologic yield was substantially 
higher (44%) in children with a history of adult TB contact. An increment in the diagnostic 
yield (22%) was also found in children who had not been diagnosed clinically, but were 
diagnosed by sputum induction. A second sputum induction test increased the diagnostic 
yield by 34% (29). These results show that it is possible to conduct microbiological 
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assessments to help make and confirm the diagnosis of TB in children, and detect patients in 
whom the diagnosis may have been missed clinically. Microbiological confirmation resulted 
in almost a quarter more children being treated than would have been treated on clinical 
grounds (29).  
In children who have complicated or severe TB disease, HIV infection, suspected drug-
resistant TB, or an uncertain diagnosis, microbiological confirmation is preferred, even 
mandatory, in order to guide therapy (36).  Studies show that HIV infection and immune 
suppression do not reduce the yield from smear microscopy for AFB in children with TB (15, 
59).  
4.1.8 TB Score Charts 
The diagnosis of TB in children relies on careful and thorough assessment from a careful 
history, clinical examination and relevant investigations, i.e. TST, chest x-ray, sputum smear 
microscopy, or the collection of appropriate clinical specimens for microbiological 
assessment. Existing diagnostic tests for TB in children have their shortcomings, and the full 
range of diagnostic tests are often not available in settings where the vast majority of TB 
cases are diagnosed (36), prompting the need for classification systems such as that 
promulgated by the WHO (41,36). As a result of the difficulty of confirming TB in children, 
some countries have adopted the use of score charts (36), but these are difficult to validate 
because of a lack of a diagnostic gold standard (15, 60). Score charts have been found to 
perform particularly poorly in children with ‘Suspect’ PTB (36), and in children who are also 
HIV-infected (61). A prospective study conducted at a mission hospital in Zambia in 1999, 
found that the paediatric TB score chart that was developed for resource-poor countries 
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showed very low specificity (25%) (61), which led to over-diagnosis of TB and unnecessary 
use of costly anti-tuberculous drugs (61).  
4.1.9 WHO TB Classification 
The majority of children evaluated at the two outpatient departments had ‘Probable’ TB, as 
defined by the WHO classification system for childhood TB (41). This was based on the high 
prevalence of positive TST reactions in the cohort, and (in the CH cohort) on suggestive 
chest x-ray findings. Of the seven criteria suggested to guide work up of TB in a  child, only 
five criteria were used by clinicians making a diagnosis of TB in the majority (65%) of 
children notified with TB at the ambulatory setting at JGH. Staff at CH exhibited a more 
thorough clinical approach, using six or seven criteria in their decision making process in 
82% of their patients (Table 3.4). 
A study from Cape Town which looked at the criteria used for the notification of childhood 
TB in a high-incidence area, demonstrated that the majority of children (72%) were also 
diagnosed with ‘Probable’ TB; this was based mainly on a diagnostic chest x-ray which 
made up 33% of their cohort (39).  
It is concerning that so few children (4%) were diagnosed with ‘Suspect’ TB in the cohort 
described in our study; this may imply that children with little clinical evidence of the 
disease may have had a missed diagnosis of TB. The lack of definitive diagnostic tests for 
childhood TB remains a dilemma for both the clinician and the epidemiologist and this will 
remain a major setback in identifying and confirming TB in children with ‘Suspect’ TB, and 
will continue to contribute to the high morbidity and mortality of childhood TB if such 
children have a missed or delayed diagnosis. Failure to confirm a diagnosis of TB in 
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suspected cases remains a major constraint in paediatric TB research including the 
epidemiology, pathogenesis, treatment, and chemoprophylaxis (57). The graduated 
approach to diagnosing childhood TB formulated by WHO (7,41) helps to ascertain a level 
of certainty with which the diagnosis can be made (39) and may hence assist with the 
challenges of diagnosing childhood TB, particularly in developing countries.  
 
4.2 Limitations of this study   
This study was carried out in two paediatric outpatient departments in Johannesburg, and 
the findings described are a reflection on how TB was diagnosed and notified in tertiary 
ambulatory settings at the end of the 1990s. Considering the fact that rapid microbiological 
techniques e.g. GeneXpert diagnostic assay, and specialist resources to assist with 
interpretation of paediatric chest x-rays have become more widely available, the study 
findings may not be applicable to current TB diagnosis in these facilities, or at lower level 
hospitals and primary healthcare facilities. With the availability of more improved diagnostic 
techniques, any nursing professional or doctor working in the ambulatory setting should be 
trained in the collection of sputum, nasopharyngeal aspirates or gastric aspirates. With 
planning, all of these specimens can be collected at primary, secondary or tertiary level. For 
adenitis, which is the other form of TB seen in the ambulatory setting, a fine needle aspirate 
should be done and sent for cytology and TB culture. A greater awareness of the role which 
HIV plays in predisposing children to TB disease has emphasised the importance of HIV 
screening, and interpretation of CXRs and TST responses in the light of HIV test results, 
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which was not the case in this study in the outpatient departments in the late 1990s. This 
study can lead on to a current audit of ambulatory paediatric TB diagnosis.  
The signs and symptoms commonly used to aid in the diagnosis of childhood TB are not 
specific, especially in areas where TB is endemic and complicated by poor socio-economic 
environments. The study cohort may have been enriched for children whose immunological 
and nutritional profiles would have resulted in TST positivity, and a diagnosis of ‘Probable 
TB’ based on this finding.  
The TST is an important component in the diagnosis of childhood TB, particularly in the 
ambulatory setting. Problems in the reliability of the test can occur if technique is poor, and 
with differing potency of tuberculin antigens. Although there is mixed uniformity in 
tuberculin which may affect interpretation (32), the product used by the Paediatric facilities 
in Johannesburg is obtained from one source (Statens Serum Institut, Copenhagen, 
Denmark) and so would not be expected to have affected TST interpretation at the study 
outpatient departments.  
Microbiological isolation (i.e. culture) of MTB from sputum, gastric aspirates or lymph node 
aspirates forms the gold standard test through which a diagnosis of TB can be made. In 
children, confirmation of the diagnosis by this method has been a cumbersome and difficult 
task and is rarely done in outpatient departments. Furthermore, the finding of organisms on 
direct smear from gastric aspirates has a low specificity since false positives may be 
produced by other mycobacteria or acid-fast organisms (32).    
Interpretation of chest radiographs is also a process marked by inconsistencies among 
different readers and between the opinions of the same reader on different occasions (7). 
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Reliability will be dependent on those reading the x-rays. Hilar lymphadenopathy may be 
difficult to detect on the chest radiographs and this is a major radiological criterion for the 
diagnosis of childhood TB (39). A lateral film is of great assistance, and should be taken when 
PTB is suspected (62). 
Incomplete clinical notes and difficulties in retrieving patient folders from hospital records 
departments may impact negatively on the quality of data, especially when undertaking 
retrospective studies. In this study, records for each of the patients were obtained for review, 
but inconsistent reporting by different clinicians would be expected to have impacted on the 
consistency of the data. Furthermore, by basing the study cohort finding strategy on review 
of notification booklets, we may have missed a subset of children diagnosed with TB but who 
were not notified with the condition at hospital-based notification centres. 
The complete lack of HIV infection status data collection in this study reflects the prevailing 
clinical practice in South African outpatient departments in the late 1990s. As childhood TB 
is commonly associated with HIV co-infection, it is problematic that this important data field 
was not available for analysis in this study. The high prevalence of positive TST reactions in 
the cohort of children described in this study would suggest that many children were 
probably HIV-uninfected: at the time of study conduct, in the late 1990s, there was no South 
African ART rollout infrastructure, and very few HIV-infected children in need of ART were 
receiving this therapy. HIV-infected children with TB at the time that this study was 
conducted would be expected to have had severe immunosuppression, and may not have 
produced a robust TST response to tuberculin. They may also have bypassed the outpatient 
setting, and have been diagnosed with TB as inpatients.  
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  4.3 Conclusion  
Analysing the data extracted from the patient records from the two paediatric outpatient 
departments, this study has been able to conclude that criteria being used to diagnose 
childhood TB are in accordance with the recommended WHO criteria suggested for the 
diagnosis of childhood TB. However, there is evidence suggesting that clinical staff at CH 
were more compliant with the WHO algorithm than were the staff at JGH. Children notified 
for TB at CH tended to have a more thorough work-up (with at least 82% being evaluated 
using at least six or seven clinical parameters recommended to guide child TB diagnosis). 
The majority of children in both outpatient departments (CH, 90%; JGH, 96%) were 
classified as ‘Probable’ TB cases, and the proportion of ‘Confirmed’ TB cases in both 
outpatient departments was minimal (CH, 4%; JGH, 2%). These findings indicate that the 
WHO recommended approach (Appendix 1) is being practised and followed up with the 
investigatory tools that are available in the two outpatient departments.  
That few of the children had an outpatient diagnosis of ‘Suspect’ TB is concerning, and may 
indicate that a TB diagnosis was missed in children who may have had the disease but 
whose clinical presentation did not alert clinicians to a possible diagnosis of the condition.  
Mantoux responses and chest x-ray features tended to steer clinicians towards a diagnosis 
of TB in this cohort. TSTs done and which came out positive (CH, 88%; JGH, 84%) indicate 
that, at the time of study conduct in the late 1990s, TST was the major identifying 
diagnostic tool in the two outpatient departments to diagnose ‘Probable’ TB. The use of 
chest x-rays in the two departments varied, highlighting the discrepancies and 
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inconsistencies in radiological diagnosis of paediatric PTB. Lack of microbiologic 
confirmation of TB was a major short-coming in both outpatient departments, in which the 
majority of children did not have specimens submitted (CH, 92%; JGH, 98%).  
Increasing awareness of ancillary diagnostic tools, e.g., HIV testing in child TB suspects, and 
microbiologic confirmation of MTB disease using sputum induction and/or gastric 
aspiration and fine needle aspiration in outpatient environments will help in improving the 
diagnostic practices for confirming TB. 
Morbidity and mortality due to childhood TB has increased with the HIV epidemic; there is 
now a need to increase efforts of using more reliable methods and diagnostic tools to 
diagnose paediatric TB infection and/or disease in the outpatient setting. Strategies such as 
contact tracing, by targeting families ‘at risk’ for TB (as identified by a sentinel adult or 
child TB case), would be expected to enhance the identification of TB suspects. 
 
4.4 Recommendations 
Successful management of the TB epidemic in children relies on careful diagnosis with 
thorough assessment of all evidence derived from a careful history, clinical examination and 
relevant investigations. This, straightforward approach is now under threat in settings with 
a high HIV prevalence as interpretation of diagnostic methods used at the time of this study 
will require greater awareness in interpreting these results as a lot of overlap is seen in 
clinical presentation between children with TB and HIV, and HIV confounds the TST and 
chest x-ray based diagnosis of childhood TB. This calls for the following recommendations: 
51 
 
a) An updated audit, interrogating ambulatory paediatric TB diagnosis at the facilities 
investigated in this study; 
b) Adopting standardised approaches to the management programmes based on best 
available evidence and recent research to assist in streamlining diagnostic methods 
for childhood TB;  
c) Engagement and training of all healthcare workers who provide care to children 
(including paediatricians, medical officers, nurses and allied medical staff) regarding 
the diagnostic approach to childhood TB in the outpatient setting; 
d) Improve current existing practices in the prevention programmes and screening 
programmes to enable earlier detection of possible TB cases and utilize INH 
preventive therapy for eligible clients ,  e.g. TB contact tracing; 
e) Identify areas where criteria being used to diagnose childhood TB in the ambulatory 
settings could be improved;  
f) Encourage use of recent advances in diagnostic techniques such as the GeneXpert 
diagnostic assay on sputum and gastric aspirates and fine needle aspirates; 
g) Community education and involvement to increase awareness of signs and symptoms 
of TB; 
h) Primary healthcare integration of TB services; 
i) Frequent updates of National TB programmes and guidelines, in order to keep 
abreast of developments in the field of TB case management; 
Current management programmes of TB in children still have room for improvement to 
decrease the morbidity and mortality in child TB cases. Further research opportunities that 
could be undertaken include: 
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a) Better understanding of the epidemiology of childhood TB, especially with the setting 
of the HIV epidemic; 
b) Development and use of better and affordable diagnostic techniques which will show 
more specificity for MTB, and which will be unaffected by prior BCG vaccination or 
exposure to other environmental mycobacteria. The recently introduced GeneXpert 
diagnostic test is specific for identifying the MTB bacillus and  has a far shorter turn-
around time than the currently used microscopy and culture techniques; research 
opportunities can be undertaken to implement this method in outpatient and 
ambulatory settings  for hastening diagnosis of childhood TB and enhancing 
diagnostic certainty.    
c) Improve systems for implementation of current available procedures, e.g. enhancing 
outpatient capacity to safely conduct sputum, induced sputum, gastric aspirate and 
fine needle specimen collections. 
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Appendix 1: World Health Organization provisional guidelines for the diagnosis of 
pulmonary tuberculosis in children (41) 
 
 
 
A. Suspect  
      Tuberculosis 
 
B. Probable 
Tuberculosis 
C. Confirmed 
Tuberculosis  
1.)An ill child with a history 
of contact with a confirmed 
case of pulmonary 
tuberculosis. 
2.)Any child: 
2.1 Not regaining 
normal health after 
measles or 
whooping cough; 
2.2  With loss of weight, 
cough and wheeze 
not responding to 
antibiotic therapy 
for respiratory 
disease; 
2.3  With painless 
swelling in a group 
of superficial nodes.  
A suspect case and any of 
the following: 
1. Positive (> 10mm) 
induration on 
tuberculin testing; 
2. Suggestive 
appearances on 
chest radiograph; 
3. Suggestive histologic 
appearances of 
biopsy material; 
4. Favourable response 
to specific 
antituberculous 
therapy 
1. Detection by 
microscopy or 
culture of tubercle 
bacilli from 
secretions or tissues, 
OR; 
2. The identification of 
the tubercle bacilli as 
Mycobacterium 
tuberculosis by 
culture 
characteristics.   
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Appendix 2: WHO Recommended approach to diagnosis of TB in children, 2006 (36) 
Box 1 
 
1. Careful history (including history of TB contact and symptoms consistent with 
TB) 
2. Clinical examination (including growth assessment) 
3. Tuberculin skin testing 
4. Bacteriological confirmation whenever possible 
5. Investigations relevant for suspected pulmonary TB and suspected 
extrapulmonary TB 
6. HIV testing 
 
 
Box 2 
 
SITE OF DISEASE PRACTICAL APPROACH TO DIAGNOSIS 
Peripheral Lymph Nodes  
(especially cervical) 
Fine-needle aspiration  
Miliary TB Chest X-ray 
TB Meningitis Lumbar puncture (and computerized 
tomography brain scan where available) 
Pleural Effusion Pleural tap  
Abdominal TB Abdominal ultrasound and tap ascitic fluid 
Osteoarticular TB X-ray, joint tap or synovial biopsy  
Pericardial TB Cardiac ultrasound and Pericardial tap 
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Appendix 3: Data Abstraction Sheet 
Data extracted from patient clinical records at CH and JGH  
_____________________________________________________________________________ 
Demographics: 
Outpatient hospital file number 
Date of birth 
Gender 
Date of attendance to the outpatient department 
Residential suburb 
  ___________________________________________________________________________________ 
Patient History: 
Presenting complaint 
Duration of presenting complaints (days/weeks) 
Clinical History interrogated: fever, cough and duration, loss of appetite, weight loss, night 
sweats, neck swellings). 
History of contact with an adult PTB case  Yes / No 
____________________________________________________________________________________ 
Clinical Examination: 
Weight (kg) 
Presence of clinical features:  
 Fever 
 Upper respiratory tract infection 
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 Bronchopneumonia 
 Lymphadenopathy 
_____________________________________________________________________________________ 
Tuberculin Skin Test: 
Tuberculin skin test done or not done 
If done, on reading, diameter of induration as recorded in the clinical notes  
Recorded as positive or negative on the data information sheet  
_____________________________________________________________________________ 
X-ray Findings: 
CXR done or not done 
If done, x-ray findings as recorded in the clinical notes 
_____________________________________________________________________________________ 
Microbiology Results: 
Sputum or gastric washings taken from the patient as recorded in the clinical notes 
If taken, microscopy & culture results as recorded in the clinical notes. 
 
 
 
 
 
 
 
 
 
 
 
57 
 
 
REFERENCES 
1. World Health Organisation. TB: a global emergency; WHO report on the TB 
Epidemic. WHO/TB/94; 177. Geneva: WHO, 1994.   
 
2. Sudre P, ten Dam G, Kochi A. Tuberculosis: A global overview of the situation today. 
Bull World Health Organ, 1992; 70: 149 – 159. 
 
3. Tuberculosis control and research strategies for the 1990’s: Memorandum from a 
WHO meeting. Bull World Health Organ, 1992; 70(1): 17 – 21.  
 
4.  World Health Organisation. Report on Infectious Diseases: Removing obstacles to 
healthy development. WHO/CDS/99.1 WHO, 1999. 
 
5. Perkins D.R. Regular reporting of TB in the SAMJ. S Afr Med J, 1996; 86: 271 – 272.   
6. Beyers N, Gie R.P, Schaaf H.S, van Zyl S, Nel E.D, Talent J.M, Donald P.R. Delay in the 
diagnosis, notification and initiation of treatment and compliance in children with 
tuberculosis. Tuber Lung Dis, 1994; 75: 260 – 265. 
 
7. Schaaf H.S, Beyers N, Gie R.P, Nel E.D, Smuts N.A, Scott F.E, Donald P.R, Fourie P.B. 
Respiratory tuberculosis in childhood: the diagnostic value of clinical features and 
special investigations. Pediatr Infect Dis J, 1995; 14: 189 – 194.     
 
8. Ghandi N.R, Nunn P, Dheda K, Schaaf H.S, Zignol M, van Soolingen D, Jensen P, Bayona 
J. Multidrug-resistant and extremely drug-resistant tuberculosis: a threat to global 
control of tuberculosis. Lancet, 2010; 375: 1830 – 1843.  
 
9. Iseman M.D, Sbarbaro J.A. Short course chemotherapy of tuberculosis. Am Rev Respir 
Dis, 1991; 143: 697 – 698.  
 
10. Boehme C.C, Nabeta P, Hillemann D, Nicol M.P, Shenai S, Krapp F, Allen J, Tahirli R.  
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med, 2010; 
336 (11): 1005 – 1015.  
 
11. World Health Organisation. Global Tuberculosis Report, 2013. Available at: 
http://www.who.int/tb/publications/global_report/en/ (Accessed 10 December 
2013).  
 
58 
 
12. Department of Health, Republic of South Africa. Guidelines for Tuberculosis 
Preventive therapy among HIV infected individuals in South Africa, 2010. Pretoria, 
South Africa: Department of Health, 2010. Available at: 
www.kznhealth.gov.za/medicine/tb2010.pdf (Accessed 09 April 2013). 
 
13.Corbett E.L, Marston B, Churchyard G.J, De-Cock K.M. Tuberculosis in Sub-Saharan               
Africa: opportunities, challenges and change in the era of antiretroviral treatment. 
Lancet, 2006; 367: 926 – 937 
 
14. Wood R, Johnstone-Robertson S, Uys P, Hargrove J, Middelkoop K, Lawn S, Bekker 
L.G. Tuberculosis transmission to young children in a South African community: 
modelling household and community infection risks. Clin Infect Dis, 2010; 51(4): 401 – 
408. 
 
15. World Health Organisation. Guidance for National Tuberculosis and HIV 
programmes on the management of tuberculosis in HIV-infected children: 
Recommendations for a public health approach. WHO, 2010. Available at: 
www.tbonline.info/media/uploads/documents/pub_tbhivchildfinaldoc_webversion2.p
df (Accessed 22 September 2011). 
 
16. Jeena P.M, Pillay P, Pillay T, Coovadia H.M. Impact of HIV -1 co – infection on 
presentation and hospital – related mortality in children with culture proven 
pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis, 2002; 6(8): 672 - 
678.  
 
17. World Health Organisation. Guidance on provider-initiated HIV testing and 
counselling in health facilities. Geneva, Switzerland; WHO, 2007. 
 
       18. Elenga N, Kouakoussui K.A, Bonard D, Fassinou P, Anaky M.F, Wemin M.L, Dick-   
        Amon-Tanoh F, Rouet F et al. Diagnosed Tuberculosis During the follow-up of a    
        cohort of Human Immunodeficiency Virus – infected Children in Abidjan, Cote    
        d’Ivoire. Pediatr Infect Dis J, 2005; 24: 1077 – 1082. 
 
19. Health Systems Trust. Health Indicators: Mother-to-child transmission rate of HIV 
<2 months of age.  Available at: http://indicators.hst.org.za/healthstats/326/data 
(Accessed 10 December 2013).   
 
20. Hesseling A.C, Cotton M.F, Jennings T, Whitelaw A, Johnson L.F, Eley B, Roux P, 
Godfrey-Faussett P, Schaff H.S. High incidence of tuberculosis among HIV-infected 
59 
 
infants: Evidence from a South African population based study highlights the need for 
improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108 – 114.  
 
21. Marais B. J, Graham S.M, Cotton M.F, Beyers N.  Diagnostic and management 
challenges for childhood tuberculosis in the era of HIV. J Infect Dis, 2007; 196: S76 – 
S85.    
 
22. Palme I.B, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human 
immunodeficiency virus 1 infection on clinical presentation, treatment outcome and 
survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J, 2002; 
21: 1053 – 1061. 
 
23. Wilkinson D, De Cock K.M. Tuberculosis control in South Africa – time for a new 
paradigm? S Afr Med J, 1996; 86: 33 – 35.    
  
24. Kochi A. The global tuberculosis situation and the new control strategy of the World 
Health Organisation. Tubercle, 1991; 72(1): 1 – 6. 
 
25. Gie R.P, Beyers N,  Schaaf H.S, Donald P.R. Missed opportunities in the diagnosis of 
pulmonary tuberculosis in children. S Afr Med J, 1993; 83: 263.   
 
26. Donald P.R, Beyers N. Adolescent tuberculosis. S Afr Med J, 1996; 86: 231 – 233 
(Editorial).   
 
27. Wallgren A. Pulmonary tuberculosis. Relation of childhood infection to the disease 
in adults. Lancet, 1938; 231: 417 – 420.  
 
28. Kibel M.A, Wagstaff L.A. Child Health for All. A Manual for Southern Africa. 2nd 
Edition, Oxford University Press. Cape Town, 1995; section 10: 277 – 284.       
 
29. Moore H. A, Apolles P, de Villiers P.J.T, Zar H.J. Sputum induction for microbiological 
diagnosis of childhood pulmonary tuberculosis in a community setting. Int J Tuberc 
Lung Dis, 2011; 15(9): 1185 – 1190.  
 
30. Wright C.A, Warren R.M, Marais B.J. Fine needle aspiration biopsy: an undervalued 
diagnostic modality in paediatric mycobacterial disease. Int J Tuberc Lung Dis, 2009; 
13(12): 1467 – 1475.  
 
60 
 
31. Gie R.P, Beyers N, Schaaf H.S, Nel E.D, Smuts N.A, van Zyl S. TB or not TB? An 
evaluation of children with an incorrect initial diagnosis of pulmonary tuberculosis. S 
Afr Med J, 1995; 85: 658 – 662.        
 
 
32. Kibel M.A, Hussey G. Problems in the diagnosis of childhood tuberculosis. S Afr Med 
J, 1990; 77: 379 – 381 (Editorial).   
 
33.Marais B.J, Hesseling A.C, Gie R.P, Schaaf H.S, Enarson D.A, Beyers N. The 
bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis, 2006; 42 
(8): e69 – e71 (Section: 1.1.4.3) 
 
34. Marais B.J, Gie R.P, Hesseling A.C, Schaaf H.S, Lombard C, Enarson D.A, Beyers N.  
A refined symptom-based approach to diagnose pulmonary tuberculosis in children. 
Pediatrics, 2006; 118: e1350 – 1359. 
 
35.Mcnally L.M, Jeena P.M, Gajee K, Thula S.A, Sturm A.W, Cassol S, Tomkins A.M,          
Coovadia H.M, Goldblatt D. Effect of age, polymicrobial disease, and maternal HIV status 
on treatment response and cause of severe pneumonia in South African children: a 
prospective descriptive study. Lancet, 2007; 369: 1440 - 1451    
 
36. World Health Organisation. Guidance for National Tuberculosis and HIV 
programmes on the management of tuberculosis in children. WHO/HTM/TB/2006.37 
WHO/FCH/CAH/2006.7. Geneva, Switzerland: WHO, 2006. 
 
37.Kibel M.A, Wagstaff L.A. Child Health for All: A Manual for Southern Africa. 1st 
Edition, Oxford University Press. Cape Town, 1991; section 7: 240 – 241 
 
38. Cammock R.M, Miller F.J. Tuberculosis in young children. Lancet, 1953; 1: 158 – 160. 
 
39. Stoltz A.P, Donald P.R, Strebel P.M, Talent J.M. Criteria for the notification of 
childhood tuberculosis in a high incidence area of the Western Cape Province. S Afr Med 
J, 1990; 77: 385 – 386. 
 
40. Jacobs M, Yach D, Fisher S, Kibel M, Hatting S, Coetzee G. Management of children 
with tuberculosis in a local authority of Cape Town. S Afr J Epidemiol Infect, 1987; 2: 15 
– 18.    
 
61 
 
41.World Health Organisation. Provisional guidelines for the diagnosis and 
classification of the EPI target diseases for primary health care, surveillance and special 
studies. (EPI/GEN/83/4). Geneva: WHO, 1983 
 
42.Woods D. Child Health Care. A learning programme for professionals. Version 1.0, 
Electric Book Works, 2007; Ch 8: 142. 
 
43. Marais B.J, Gie R.P, Obihara C.C, Hesseling A.C, Schaaf H.S, Beyers N. Well defined 
symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis 
Child, 2005; 90: 1162 - 1165. 
 
44. Marais B. J, Gie R.P, Schaaf H.S, Hesseling A.C, Obihara C.C, Nelson L.J, Enarson D. A, 
Donald P.R, Beyers N. The clinical epidemiology of childhood pulmonary tuberculosis: a 
critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis, 2004; 
8 (3): 278 – 285.  
 
45. Bentley F.J, Grzybowski S, Benjamin B. Tuberculosis in childhood and adolescence. 
The National Association for the Prevention of Tuberculosis. London, UK; Waterlow and 
Sons Ltd, 1954: 217 – 238. 
 
46. Marais B. J, Gie R.P, Schaaf H.S, Hesseling A.C, Obihara C.C, Starke J.J, Enarson D.A, 
Donald P.R, Beyers N. The natural history of childhood intra-thoracic tuberculosis: a 
critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis, 2004; 
8 (4): 392 – 402.   
 
47. Holmes C.B, Hausler H, Nunn P. A review of sex differences in the epidemiology of 
tuberculosis. Int J Tuberc Lung Dis, 1998; 2 (2): 96 – 104. 
 
48. Zachariah R, Spielmann M.P, Harries A.D, Salaniponi F.M.L. Moderate to severe 
malnutrition in patients with tuberculosis is a risk factor associated with early death. 
Trans R Soc Trop Med Hyg, 2002; 96: 291 – 294. 
 
49. Cundall D.B. The diagnosis of pulmonary tuberculosis in malnourished Kenyan 
children. Ann Trop Paediatr, 1986; 6: 249 – 255. 
 
50. Moore D.P, Schaaf H.S, Nuttall J, Marais B.J. Childhood tuberculosis guidelines of the 
Southern African Society for Paediatric Infectious Diseases. South Afr J Epidemiol Infect, 
2009; 24(3): 57 – 68. 
 
62 
 
51. Tostman A, Kik V.S, Kalisvaart N.A, Sebek M.M, Verver S, Boeree M.J, van Soolingen 
D. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis 
in a large cohort in the Netherlands. Clin Infect Dis, 2008; 47: 1135 – 1142. 
  
52. Department of Health, Republic of South Africa. National Tuberculosis Management 
Guidelines, 2009. Pretoria, South Africa: Department of Health, 2009. Available at: 
http://familymedicine.ukzn.ac.za/Libraries/Guidelines_Protocols/TB_Guidelines_2009.
sflb.ashx (Accessed 08 April 2011).  
 
53. Jacobs R.F, Starke J.R. Tuberculosis in children. Med Clin North Am, 1993; 77(6): 
1335 – 1351. 
 
54. Madhi S.A, Huebner R.E, Doedens L, Aduc T, Wesley D, Cooper P.A. HIV-1 co-
infection in children hospitalised with tuberculosis in South Africa. Int J Tuberc Lung 
Dis, 2000; 4: 448 – 454. 
 
55. Zwi K, Pettifor J, Soderlund N, Meyers T. HIV infection and in-hospital mortality at 
an academic hospital in South Africa. Arch Dis Child, 2002; 83: 227 – 230. 
 
56. Dramowski A, Coovadia A, Meyers T, Goga A. Identifying missed opportunities for 
early intervention among HIV-infected paediatric admissions at Chris Hani 
Baragwanath Hospital, Soweto, South Africa. S Afr J HIV Med, 2011; 12: 16 – 23.  
 
57. Osborne C.M. The challenge of diagnosing childhood tuberculosis in a developing 
country. Arch Dis Child, 1995; 72: 369 – 374. 
 
58. Weismuller M.M, Graham S.M, Claessens N.J.M, Meijnen S, Salaniponi F, Harries A.D.  
Diagnosis of childhood tuberculosis in Malawi. Int J Tuberc Lung Dis, 2002; 6(5): 432 – 
438.  
 
59. Hesseling A.C, Westra A.E, Werschkull H, Donald PR, Beyers N, Hussey G.D, El-Sadr 
W, Schaaf H.S. Outcome of HIV infected children with culture confirmed tuberculosis. 
Arch Dis Child, 2005; 90: 1171 – 1174. 
 
60. Hesseling A.C, Schaaf H.S, Gie R.P, Starke J.R, Beyers N. A critical review of diagnostic 
approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis, 2002; 
6: 1038 – 1045.  
 
61. Van Rheenen P. The use of a paediatric tuberculosis score chart in an HIV-endemic 
area. Trop Med Int Health, 2002; 7: 435 – 441. 
63 
 
 
62. Gie R. Diagnostic Atlas of Intrathoracic Tuberculosis in Children. A guide for low 
income countries. IUALTD, 2003.  
 
